Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...
According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.
Bain Capital is considering a possible sale of Italmatch Chemicals SpA, which could be valued at €1.5 billion ($1.6 billion) ...
The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, in a deal that could value it at ...
Frontline Road Safety today announced that Bain Capital has agreed to acquire the Company from The Sterling Group.
“To do a $17 billion acquisition, we found co-investors to close on the deal in 2018,” Reeder explained said. Today, ECP is ...
Bain Capital Specialty Finance, Inc. (NYSE: BCSF or the “Company”) today announced that it has priced an offering of $350 million aggregate principal amount of 5.950% senior notes due 2030 ...
“With Bain Capital’s strategic and operational support ... continue investing in our people and services, and build upon our platform to better meet the growing demand for infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results